Related Experiment Video
Updated: Jan 29, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Mantle Cell Lymphoma: An Evolving Therapeutic Landscape
1is a staff clinician in the Lymphoid Malignancies Branch, Center for Cancer Research at the National Cancer Institute, National Institutes of Health, in Bethesda, Maryland.
Abstract:
Although there is a lack of consensus regarding the optimal management strategy of mantle cell lymphoma, novel targeted therapies show promise in extended remission.
Insights
Novel targeted therapies offer hope for extended remission in mantle cell lymphoma, despite ongoing debate about the best treatment approaches for this cancer.
Area of Science:
- Oncology
- Hematology
Background:
- Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma with variable treatment outcomes.
- Optimal management strategies for MCL remain under investigation due to its complex nature.
Purpose of the Study:
- To review the current landscape of mantle cell lymphoma management.
- To highlight the emerging role of novel targeted therapies in improving patient outcomes.
Main Methods:
- Literature review of recent clinical trials and studies.
- Analysis of data on targeted therapy efficacy and safety in MCL.
Main Results:
- Novel targeted therapies demonstrate significant potential for inducing and maintaining remission in MCL.
- These therapies may offer an alternative or adjunct to conventional treatments.
Conclusions:
- Targeted therapies represent a promising advancement in mantle cell lymphoma treatment.
- Further research is warranted to establish definitive management guidelines incorporating these novel agents.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Skeletal Muscle Relaxants: Therapeutic Uses

